119 related articles for article (PubMed ID: 7833222)
1. Responses to low dose intravenous perindoprilat infusion in salt deplete/salt replete normotensive volunteers.
MacFadyen RJ; Lees KR; Reid JL
Br J Clin Pharmacol; 1994 Oct; 38(4):329-34. PubMed ID: 7833222
[TBL] [Abstract][Full Text] [Related]
2. Studies with low dose intravenous diacid ACE inhibitor (perindoprilat) infusions in normotensive male volunteers.
MacFadyen RJ; Lees KR; Reid JL
Br J Clin Pharmacol; 1992 Aug; 34(2):115-21. PubMed ID: 1419473
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the oral angiotensin II receptor antagonist UP 269-6 or enalapril 20 mg on blood pressure and neurohormonal effects in salt-deplete man.
McIntyre M; MacFadyen RJ; Meredith PA; Menard J; Brunner HR; Insuasty J; Reid JL
J Cardiovasc Pharmacol; 1995 Jun; 25(6):994-1000. PubMed ID: 7564347
[TBL] [Abstract][Full Text] [Related]
4. Double blind controlled study of low dose intravenous perindoprilat or enalaprilat infusion in elderly patients with heart failure.
MacFadyen RJ; Lees KR; Reid JL
Br Heart J; 1993 Apr; 69(4):293-7. PubMed ID: 8387806
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic and renal responses to oral losartan potassium during salt depletion or salt repletion in normal human volunteers.
Doig JK; MacFadyen RJ; Sweet CS; Reid JL
J Cardiovasc Pharmacol; 1995 Apr; 25(4):511-7. PubMed ID: 7596116
[TBL] [Abstract][Full Text] [Related]
6. Sodium space and intravascular volume: dietary sodium effects in cystic fibrosis and healthy adolescent subjects.
Legris GJ; Dearborn D; Stern RC; Geiss CL; Hopfer U; Douglas JG; Doershuk CF
Pediatrics; 1998 Jan; 101(1 Pt 1):48-56. PubMed ID: 9417150
[TBL] [Abstract][Full Text] [Related]
7. Dose-ranging study of the angiotensin II receptor antagonist irbesartan (SR 47436/BMS-186295) on blood pressure and neurohormonal effects in salt-deplete men.
McIntyre M; MacFadyen RJ; Meredith PA; Brouard R; Reid JL
J Cardiovasc Pharmacol; 1996 Jul; 28(1):101-6. PubMed ID: 8797143
[TBL] [Abstract][Full Text] [Related]
8. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
MacFadyen RJ; Lees KR; Reid JL
Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
[TBL] [Abstract][Full Text] [Related]
9. Haemodynamic and hormonal responses to oral enalapril in salt depleted normotensive man.
MacFadyen RJ; Elliott HL; Meredith PA; Reid JL
Br J Clin Pharmacol; 1993 Mar; 35(3):299-301. PubMed ID: 8471406
[TBL] [Abstract][Full Text] [Related]
10. Neurohormonal and blood pressure responses to low-dose infusion of an orally active renin inhibitor, Ro 42-5892, in salt-replete men.
Doig JK; MacFadyen RJ; Meredith PA; Fischli W; Reid JL
J Cardiovasc Pharmacol; 1992 Dec; 20(6):875-80. PubMed ID: 1282588
[TBL] [Abstract][Full Text] [Related]
11. OACE inhibition does not interfere with acute extrarenal or renal potassium disposal in chronic renal failure.
Zwettler U; Fliser D; Nowicki M; Ritz E
Eur J Clin Pharmacol; 1994; 46(3):185-9. PubMed ID: 8070497
[TBL] [Abstract][Full Text] [Related]
12. Responses to an orally active renin inhibitor, remikiren (Ro 42-5892), after controlled salt depletion in humans.
MacFadyen RJ; Jones CR; Doig JK; Birnbock H; Reid JL
J Cardiovasc Pharmacol; 1995 Mar; 25(3):347-53. PubMed ID: 7769797
[TBL] [Abstract][Full Text] [Related]
13. Plasma-renin response to isotonic volume contraction in young salt-sensitive normotensive men.
Schorr U; Schultz C; Sharma AM
Am J Hypertens; 2002 Jan; 15(1 Pt 1):48-52. PubMed ID: 11824860
[TBL] [Abstract][Full Text] [Related]
14. Effects of captopril on arterial blood pressure, plasma renin activity and vasopressin concentration in sodium-repleted and sodium-deficient goats. A serial study during pregnancy, lactation and anestrus.
Olsson K; Fyhrquist F; Benlamlih S; Dahlborn K
Acta Physiol Scand; 1984 May; 121(1):73-80. PubMed ID: 6377825
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans.
Azizi M; Bissery A; Peyrard S; Guyene TT; Ozoux ML; Floch A; Ménard J
Clin Pharmacol Ther; 2006 Jan; 79(1):49-61. PubMed ID: 16413241
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent effects of the renin inhibitor zankiren HCl after a single oral dose in mildly sodium-depleted normotensive subjects.
Ménard J; Boger RS; Moyse DM; Guyene TT; Glassman HN; Kleinert HD
Circulation; 1995 Jan; 91(2):330-8. PubMed ID: 7805235
[TBL] [Abstract][Full Text] [Related]
17. Relationship of the renin-angiotensin system and systemic arterial pressure to sodium excretion during atrial natriuretic peptide infusion in men.
Grandis DJ; Uretsky BF; Verbalis JG; Chong TK; Puschett JB
Am J Hypertens; 1992 Nov; 5(11):793-9. PubMed ID: 1457079
[TBL] [Abstract][Full Text] [Related]
18. Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients.
Denolle T; Luo P; Guyene TT; Cazaubon C; Sissmann J; Corvol P; Ménard J
Arzneimittelforschung; 1993 Feb; 43(2A):255-9. PubMed ID: 8498973
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the pharmacokinetics and pharmacodynamics of oral doses of perindopril in normotensive Chinese and Caucasian volunteers.
Anderson PJ; Critchley JA; Tomlinson B; Resplandy G
Br J Clin Pharmacol; 1995 Apr; 39(4):361-8. PubMed ID: 7640141
[TBL] [Abstract][Full Text] [Related]
20. Effect of contrasted sodium diets on the pharmacokinetics and pharmacodynamic effects of renin-angiotensin system blockers.
Azizi M; Blanchard A; Charbit B; Wuerzner G; Peyrard S; Ezan E; Funck-Brentano C; Ménard J
Hypertension; 2013 Jun; 61(6):1239-45. PubMed ID: 23608658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
